These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 30868284)
41. Clinicopathological features, endoscopic features, and treatment analysis of gastric neuroendocrine neoplasms. Huang J; Wu X; Xu T; Li J Chin Med J (Engl); 2022 Oct; 135(20):2497-2499. PubMed ID: 36583868 [No Abstract] [Full Text] [Related]
42. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs). Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087 [TBL] [Abstract][Full Text] [Related]
43. [Gastric carcinoid in chronic atrophic gastritis with hypergastrinemia]. Höring E; Egner E; von Gaisberg U Leber Magen Darm; 1991 Mar; 21(2):83-6. PubMed ID: 2038230 [TBL] [Abstract][Full Text] [Related]
47. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up. Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024 [TBL] [Abstract][Full Text] [Related]
48. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454 [No Abstract] [Full Text] [Related]
49. [Neuroendocrine gastric carcinoma. A case report and review of current management]. Mondragón-Sánchez A; Mondragón-Sánchez R; Bernal Maldonado R; Baquera-Heredia J; Gómez-Gómez E Rev Gastroenterol Mex; 2003; 68(2):129-32. PubMed ID: 15127650 [TBL] [Abstract][Full Text] [Related]
50. Gastric carcinoids and therapeutic options. Case report and review of the literature. Dobru D; Boeriu A; Mocan S; Pascarenco O; Boeriu C; Molnar C J Gastrointestin Liver Dis; 2013 Mar; 22(1):93-6. PubMed ID: 23539397 [TBL] [Abstract][Full Text] [Related]
51. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087 [TBL] [Abstract][Full Text] [Related]
52. Gastric carcinoids (neuroendocrine neoplasms). Kidd M; Gustafsson B; Modlin IM Gastroenterol Clin North Am; 2013 Jun; 42(2):381-97. PubMed ID: 23639647 [TBL] [Abstract][Full Text] [Related]
53. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum]. Shimizu N; Kaminishi M Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318 [TBL] [Abstract][Full Text] [Related]
55. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895 [TBL] [Abstract][Full Text] [Related]
56. Gastric outlet obstruction and cutaneous metastasis in adenocarcinoid tumor of stomach - unusual presentations with cytologic and ultra structural findings. Rekhi B; Saxena S; Indian J Cancer; 2005; 42(2):99-101. PubMed ID: 16141510 [TBL] [Abstract][Full Text] [Related]
57. Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease. Hendifar AE; Marchevsky AM; Tuli R J Thorac Oncol; 2017 Mar; 12(3):425-436. PubMed ID: 27890494 [TBL] [Abstract][Full Text] [Related]
58. Multiple gastric carcinoids associated with hypergastrinemia. A review of five cases with clinicopathological analysis and surgical strategies. Okada K; Kijima H; Chino O; Matsuyama M; Okamoto Y; Yamamoto S; Tanaka M; Inokuchi S; Makuuchi H Anticancer Res; 2005; 25(6C):4417-22. PubMed ID: 16334119 [TBL] [Abstract][Full Text] [Related]
59. [A clinico-pathological study of neuroendocrine tumors in stomach]. Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506 [TBL] [Abstract][Full Text] [Related]